Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Iskander

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Lymphoma, Myeloma & Leukemia|October 6, 2018
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple MyelomaXavier Leleu, Thomas G Martin, Hermann Einsele, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 4, 2003
Cardiac angiosarcoma: an unusual presentation simulating mitral stenosis and constrictive-effusive pericarditisJuan Carlos Plana, Sherif S Iskander, Mary L Ostrowski, et al.
Blood|November 28, 2018
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVORMeletios Dimopoulos, David Siegel, Darrell J White, et al.
Journal of the American College of Cardiology|November 6, 2001
Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomographyS Shimoni, W A Zoghbi, F Xie, et al.
Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.
Journal of the American College of Cardiology|December 19, 2006
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarctionJohn J Mahmarian, Leslee J Shaw, Neil G Filipchuk, et al.
Journal of the American College of Cardiology|December 19, 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarctionJohn J Mahmarian, Habib A Dakik, Neil G Filipchuk, et al.
Blood Advances|July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trialsAjai Chari, A Keith Stewart, Stuart D Russell, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Lymphoma, Myeloma & Leukemia|October 6, 2018
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple MyelomaXavier Leleu, Thomas G Martin, Hermann Einsele, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 4, 2003
Cardiac angiosarcoma: an unusual presentation simulating mitral stenosis and constrictive-effusive pericarditisJuan Carlos Plana, Sherif S Iskander, Mary L Ostrowski, et al.
Blood|November 28, 2018
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVORMeletios Dimopoulos, David Siegel, Darrell J White, et al.
Journal of the American College of Cardiology|November 6, 2001
Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomographyS Shimoni, W A Zoghbi, F Xie, et al.
Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.
Journal of the American College of Cardiology|December 19, 2006
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarctionJohn J Mahmarian, Leslee J Shaw, Neil G Filipchuk, et al.
Journal of the American College of Cardiology|December 19, 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarctionJohn J Mahmarian, Habib A Dakik, Neil G Filipchuk, et al.
Blood Advances|July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trialsAjai Chari, A Keith Stewart, Stuart D Russell, et al.
Pageof 3